Search filters

List of works by Eva Pers Winning Iepsen

Adults with pathogenic MC4R mutations have increased final height and thereby increased bone mass

scientific article published on 30 August 2019

GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women

scientific article published on 4 June 2015

GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report

scientific article published on 21 April 2020

Glucose ingestion causes cardiac repolarization disturbances in type 1 long QT syndrome patients and healthy subjects.

scientific article published on 8 April 2017

Instrumentalization of Eating Improves Weight Loss Maintenance in Obesity

scientific article published on 6 December 2017

KCNQ1 long QT syndrome patients have hyperinsulinemia and symptomatic hypoglycemia

scientific article

Liraglutide for Type 2 diabetes and obesity: a 2015 update

scientific article published on July 2015

Major rapid weight loss induces changes in cardiac repolarization

scientific article published on 10 February 2016

Patients With Long-QT Syndrome Caused by Impaired hERG-Encoded Kv11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated With Reactive Hypoglycemia

scientific article

Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist

scientific article published on 31 May 2018

Proteomics reveals the effects of sustained weight loss on the human plasma proteome

scientific article

Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3-36.

scientific article

Therapies for inter-relating diabetes and obesity - GLP-1 and obesity

scientific article published on 26 September 2014

Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss.

scientific article

Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB.

scientific article published on 21 November 2017

Weight loss and weight maintenance obtained with or without GLP-1 analogue treatment decrease branched chain amino acid levels

Paulina is supported by:

About Paulina

Help